Tag Archives: TXMD

Hot Stocks To Own Right Now

Mark the day tax returns are duewith some deals and freebies.

Deals range from discounted drinks and meals to free paper shredding toa great way to eliminate the stress of filing at the last minute.

Through April 22,HydroMassagelocations nationwide are giving away massages on theiruser-controlled massage beds for the companys ninth annual Tax Week promotion. This deal is available at 1,300 locations nationwide, including Planet Fitness gyms that have the massage beds.

Visitwww.hydromassage.com/taxdayto find a list of participating locations and print acoupon. Youll need to make an appointment for non-Planet Fitness locations. Massages could be limited to 10 minutes.

The following offers are available Tuesday at participating locations unless otherwise noted:

Bob Evans:Get 30%off your entire purchase for dine-in and carry-out orders with a coupon available atwww.bobevans.com/taxday.

Hot Stocks To Own Right Now: FMC Corporation(FMC)

Advisors’ Opinion:

  • [By Ben Levisohn]

    We also want to reiterate our bullish view on the agricultural commodities and the ag-related stocks (e.g., CF Industries Holdings (CF), Mosaic (MOS), Potash Corp. of Saskatchewan (POT), FMC (FMC), AGCO, Deere). Following sharp multi-year declines, trends continue to improve.

  • [By WWW.THESTREET.COM]

    With an improving global economy, now is a great time to be a chemical company, Cramer told viewers, as he reiterated his favorites: Albemarle (ALB) and FMC Technology  (FMC) .

  • [By Beth McKenna]

    Most investors interested in gaining exposure to the lithium space should stick with investing in one or more of the large players listed on a major U.S. stock exchange:Albemarle Corporation(NYSE:ALB), FMC Corp. (NYSE:FMC), andSociedad Quimica y Minera de Chile(NYSE:SQM), or SQM. Smaller players are speculative to varying degrees, and most are unprofitable.

Hot Stocks To Own Right Now: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

Hot Stocks To Own Right Now: Xylem Inc.(XYL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

  • [By Ben Levisohn]

    Technology and Industrials are our favorite ways to buy cyclical MO. Specifically, we see the Technology Select Sector SPDR ETF (XLK) as an attractive pre-breakout idea and a likely candidate to lead the S&Ps secular advance over the coming years. Buy ideas at the stock level include: Accenture (ACN), Broadcom (AVGO), Microsoft , Texas Instruments (TXN),Visa (V),Yahoo! (YHOO). We also recommend buying the Industrial Select Sector SPDR ETF (XLI) which is reversing its year-long downtrend and in position for new highs over the coming months, in our view. Buy ideas at the stock level include: Honeywell International, Ingersoll-Rand (IR), Illinois Tool Works (ITW), 3M, Southwest Airlines (LUV), Xylem (XYL). Underlined stocks are fundamentally-rated Outperform at Oppenheimer.

Hot Stocks To Own Right Now: JinkoSolar Holding Company Limited(JKS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, energy shares fell by 0.59 percent. Meanwhile, top losers in the sector included JinkoSolar Holding Co., Ltd. (NYSE: JKS), down 8 percent, and Teekay Offshore Partners L.P. (NYSE: TOO) down 7 percent.

  • [By Paul Ausick]

    It is not often that a secondary stock offering sends a companys shares higher, but we are seeing that very phenomenon Friday morning. Chinese solar PV maker JinkoSolar Holding Co. Ltd. (NYSE: JKS) and stock image company Shutterstock Inc. (NASDAQ: SSTK) both priced secondary offerings this morning and shares in both companies have risen sharply.

  • [By Lisa Levin]

    JinkoSolar Holding Co (NYSE: JKS) dropped 9.88% to $16.87 after the company announced the offering of 3,500,000 American Depositary Shares.

    Fuwei Films (Holdings) Co (NASDAQ: FFHL) dropped 9.66% to $1.30. Fuwei Films’ trailing-twelve-month ROE is -10.85%.

  • [By Elizabeth Balboa]

    First Solar, Inc (NASDAQ: FSLR) was trading down 3.7 percent Monday, while JA Solar Holdings Co., Ltd. (ADR) (NASDAQ: JASO) was down 0.8 percent, SunPower Corporation (NASDAQ: SPWR) 4.4 percent, Canadian Solar Inc. (NASDAQ: CSIQ) 5.2 percent and JinkoSolar Holding Co., Ltd. (NYSE: JKS) 4.4 percent.

  • [By Paul Ausick]

    But the real news is the near vertical trajectory in share prices for the two stocks. This could be another manifestation of the markets hunger for some momentum plays, as we noted earlier this morning the bump to share prices for both JinkoSolar Holding Co. Ltd. (NYSE: JKS) and Shutterstock Inc. (NASDAQ: SSTK), both of which held secondary share sales this morning.

10 Stocks to Buy for Surefire Gains in 2018 and Beyond

With everyone looking ahead now to 2018, investors are getting bombarded with ideas regarding the best stocks to buy.

Everyone has their own suggestion about which stocks are going to hit the big time in the coming months, but fear not! Here we have a list of 10 sure-fire winners that tick all the boxes. These stocks to buy are not purely subjective. Instead, they have big support from the Street’s top analysts and the upside potential to match based on the average analyst price target.

I found these stocks using a nifty Top Analyst Stocks tool on TipRanks. This pulls up stocks with bullish recent ratings from multiple top analysts. Scanning through this list, I was able to identify 10 top stocks that make compelling investing opportunities right now. Just to note, I purposefully eliminated stocks that only have big upside potential because share prices are plummeting.

With that in mind, let’s dive in and see which stocks make the cut for 2018:

Stocks to Buy: Micron (MU) Stocks to Buy: Micron (MU)investorplace.com/wp-content/uploads/2017/09/mumsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/09/mumsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/09/mumsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/09/mumsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/09/mumsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/09/mumsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/09/mumsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/09/mumsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/09/mumsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/09/mumsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Over the last three months, semiconductor stock Micron Technology, Inc. (NASDAQ:MU) has received a whopping 19 buy ratings and just 3 hold ratings. As a result, the stock has a ‘Strong Buy’ analyst consensus rating. These analysts believe (on average) that Micron has big upside potential of over 30% from the current share price. This would take MU from $44.12 all the way to $57.65. Bear in mind, MU has already doubled year-to-date!

Five-star Rajvindra Gill assigned a buy rating to MU with a very confident $76 price target on Dec. 20 (72% upside). He says the market is undervaluing MU and he sees serious potential in: 1) 3D NAND transition, which generates a significant cost advantage (30%-35%); and 2) technology limitations in DRAM supply growth.

“We believe investors are focusing too heavily on a NAND pricing decline to see the big picture. With another record quarter and guide (beat revenue and EPS consensus by 5.6% and 11.4%, respectively) in the bag, Micron is on track to generate quarterly EPS of nearly $2.50 or roughly $10 per share of annualized earnings” said Gill on Dec. 20.

Note that this is a top analyst worth following. He is ranked No. 43 out of over 4,700 analysts tracked by TipRanks.

Stocks to Buy: Spark Therapeutics (ONCE)

Stocks to Buy: Spark Therapeutics (ONCE)investorplace.com/wp-content/uploads/2017/08/oncemsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/08/oncemsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/08/oncemsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/08/oncemsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/08/oncemsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/08/oncemsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/08/oncemsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/08/oncemsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/08/oncemsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/08/oncemsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />

Spark Therapeutic Inc’s (NASDAQ:ONCE) innovative gene therapy has just received a critical approval from the Food and Drug Administration. Excitingly, this is the first gene therapy to restore sight to individuals with a rare inherited eye disease that can cause blindness. The treatment, known as Luxturna, can treat both children and adults. Following the news, three analysts quickly reiterated their Spark buy ratings.

“Today’s approval marks another first in the field of gene therapy — both in how the therapy works and in expanding the use of gene therapy beyond the treatment of cancer,” said FDA commissioner Scott Gottlieb. “This milestone reinforces the potential of this breakthrough approach in treating a wide range of challenging diseases.”

Overall this ‘Strong Buy’ stock has a bullish average analyst price target of $73 (38% upside potential). We don’t know the drug’s price just yet, but Phil Nadeau, a top Cowen & Co analyst, says: “$500,000 per procedure is reasonable for a once-per-lifetime therapy that has the potential to be curative.”

Meanwhile, Raymond James’ Reni Benjamin notes that: “1) with no negative surprises, the label is slightly better than expected, only excluding the use of this gene therapy in infants under 12 months of age; 2) Spark also received a Rare Pediatric Disease Priority Review Voucher, which we estimate is worth approximately $125 million based on recent transactions.”

Stocks to Buy: Alcoa (AA) Stocks to Buy: Alcoa (AA)investorplace.com/wp-content/uploads/2016/06/aamsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/06/aamsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/06/aamsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/06/aamsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/06/aamsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/06/aamsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/06/aamsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/06/aamsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/06/aamsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Josh Hallett via Flickr (Modified)

Pennsylvania-based Alcoa Corp (NYSE:AA) is the world’s sixth largest producer of aluminum with locations all over the world. The stock is catching the attention of investors following a bullish upgrade from Credit Suisse. On Dec. 20, five-star Credit Suisse analyst Curt Woodworth ramped up his price target from $42 to $61. This now suggests 22% upside potential from the current price. Woodworth is anticipating that tighter aluminum supply will push up prices due to alumina and bauxite closures.

“We note three smelters curtailed production last week, and the government is set to sharply increase inspections in January. We expect the aluminum market to tighten into late 1Q-18 as downstream demand sharply recovers.” Plus, China’s increased commitment to environmental policy will further curtail supply according to Woodworth.

Overall, AA has a ‘Strong Buy’ rating, with only buy ratings from top analysts in the last three months. At the same time, the average analyst price target of $60 stands at 20% upside from the current share price.

Stocks to Buy: MasTec (MTZ) Stocks to Buy: MasTec (MTZ)investorplace.com/wp-content/uploads/2017/01/mtzmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/01/mtzmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/01/mtzmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Keep a close eye on Florida-based specialty contractor engineer MasTec, Inc. (NYSE:MTZ) in 2018. The company’s work spans electric power infrastructure, oil and natural gas pipelines, renewable energy facilities and wireless networks. Strength across the board has resulted in 100% Street support with seven analysts publishing recent buy ratings. Indeed, MTZ has received no hold or sell ratings from the Street for over 8 months.

“We reiterate a BUY on MTZ ahead of what we expect to be increasing 2018 estimates and an expanding multiple. With all segments poised for growth in 2018, a more diversified positive top line performance is likely to be enhanced on the bottom line by better Oil and Gas margins and a generally improving pricing and mix environment from large projects” writes top Canaccord Genuity analyst Robert Burleson. His buy rating comes with a $58 price tag (15% upside). We can also see that he has an incredible track record on his MTZ ratings with a 100% success rate and 51.6% average return.

Stocks to Buy: TherapeuticsMD (TXMD) Stocks to Buy: TherapeuticsMD (TXMD)investorplace.com/wp-content/uploads/2017/12/txmdmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/12/txmdmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/12/txmdmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

I have already banged on about TherapeuticsMD Inc (NASDAQ:TXMD) in my recent piece on top healthcare stocks. But this is an intriguing stock pick that I felt was worth including again. TXMD is a unique biotech making waves in the world of female healthcare. The company develops and commercializes products exclusively for women. Its lead product candidate is the TX-004 soft gel capsule for post-menopausal pain. This approach clearly has the backing of the Street, as TXMD has a Strong Buy analyst consensus rating.

In fact, in the last three months, TherapeuticsMD has received seven back-to-back buy ratings. Plus the $15.30 average analyst price target represents a huge 161% upside from the $6 current share price. Crucially, even the lowest price target of $9 from Noble Financial and Deutsche Bank still suggests 55% upside potential.

The most bullish analyst of the pack is top Cantor Fitzgerald analyst William Tanner. He reiterated his TXMD buy rating on Dec. 19 with a $28 price target. Tanner notes that the FDA has opted to conduct a longer Class 2 review of TX-004. But ultimately, he calls the drug ‘an important new therapy’ for atrophy. He says: “We believe the likelihood of approval is high, 85% probability, the highest we use to account for some revenue forecasting uncertainty.”

Stocks to Buy: Amazon (AMZN) Stocks to Buy: Amazon (AMZN)investorplace.com/wp-content/uploads/2016/05/amznmsn2-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/05/amznmsn2-170×93.jpg 170w” sizes=”(max-width: 728px)100vw, 728px” />Source: Mike Seyfang via Flickr

Year-to-date Amazon.com, Inc. (NASDAQ:AMZN) has already soared by 56%. But even with shares at $1,176, we can see that the Street still sees AMZN spiking over 11% to $1,311. In fact, in the last three months this stock has received an eyebrow-raising 33 buy ratings vs. just one hold rating.

The most recent rating comes from top RBC Capital analyst Mark Mahaney. He has just carried out a survey on Amazon’s intelligent personal assistant Alexa. And he likes what he sees. “Following our third annual Alexa survey, we are more impressed with the traction of these devices and more convinced of their potential long-term impact. With tens of millions of users and 20K+ skills, we see Alexa’s value prop as becoming increasingly powerful as awareness and ownership ramp. We think AMZN could see $10-$11B in Alexa-related Rev by 2020.”

In fact, recent reports suggest Alexa made a popular holiday gift. On Christmas Day, Amazon’s Alexa app took the No. 1 spots on both the U.S. Google Play and iPhone App Stores’ free app charts.

Stocks to Buy: Comcast (CMCSA) Stocks to Buy: Comcast (CMCSA)investorplace.com/wp-content/uploads/2016/09/cmcsamsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/09/cmcsamsn-170×93.jpg 170w” sizes=”(max-width: 728px)100vw, 728px” />Source: Mike Mozart via Flickr

The cable sector has been down in the dumps, but it is now looking for a comeback in 2018. And there is one company that stands out in particular: mass media king Comcast Corporation (NASDAQ:CMCSA). In the last three months, Comcast scores 10 out of 10, with 10 consecutive buy ratings from the Street. These analysts have an average price target of $45- 10% upside from the current share price.

Top Pivotal Research analyst Jeffrey Wlodarczak is confident that the stock is setup for a solid 2018. On Dec. 19, he told investors: “Recall, our belief that the cable malaise would be winding down by year-end ’17 and we continue to believe that this is the case. Comcast management’s data guidance raise in 4Q, implied material acceleration in capital returns and ’18 cable EBITDA margin expansion helped alleviate these investor fears.”

Plus, he believes that “the elimination of net neutrality laws, which effectively gave regulatory cover for video/phone competitors to freely use the cable plant, should also help with monetization.” His $50 price target translates into 22% upside potential.

Stocks to Buy: Smart Global Holdings (SGH) Stocks to Buy: Smart Global Holdings (SGH)investorplace.com/wp-content/uploads/2017/12/SGHmsn-300×150.jpg 300w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-768×384.jpg 768w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-60×30.jpg 60w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-200×100.jpg 200w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-400×200.jpg 400w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-116×58.jpg 116w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-100×50.jpg 100w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-78×39.jpg 78w, investorplace.com/wp-content/uploads/2017/12/SGHmsn-800×400.jpg 800w,https://investorplace.com/wp-content/uploads/2017/12/SGHmsn-170×85.jpg 170w” sizes=”(max-width: 950px) 100vw, 950px” />Source: Shutterstock

SGH is a global leader in specialty memory, storage and hybrid solutions for the electronics industry for over 25 years. On the back of a strong beat and raise quarter, three analysts reiterated their Smart Global Holdings Inc (NASDAQ:SGH) buy ratings on Dec. 22. Shares popped 10% on the news. And now these analysts say shares can move another 25% from the current share price to hit $43.

SGH CEO Iain MacKenzie commented that the company enjoyed “strength across the board.” Revenue, gross margin and earnings-per-share all exceeded the high ends of previous guidance. He now has even higher hopes for the coming quarters, due to Brazil and the improving global memory market. Indeed, current strength in Brazil is expected to continue throughout the year as the economy recovers.

Stocks to Buy: Aerie Pharmaceuticals (AERI) Stocks to Buy: Aerie Pharmaceuticals (AERI)investorplace.com/wp-content/uploads/2017/07/biotechmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-91×50.jpg 91w,https://investorplace.com/wp-content/uploads/2017/07/biotechmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/07/biotechmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Eye disease pharma Aerie Pharmaceuticals Inc (NASDAQ:AERI) received an early holiday gift from the FDA. The US regulatory body has just approved Aerie’s lead product Rhopressa two months ahead of schedule. Aerie is now set to hire a 100-person strong sales force in preparation for launch in 2Q18.

“The FDA has approved Aerie’s Rhopressa drug for the treatment of patients with open angle glaucoma or ocular hypertension. We see this announcement as a positive for the company and also a positive read-through for the potential upcoming approval of Roclatan in 2019,” writes five-star Mizuho analyst Difei Yang.

Intriguingly, she also adds: The approval of Rhopressa reinforces our view that Aerie Pharmaceuticals is a strong takeout candidate.” Yang has an $87 price target on the stock and a very strong AERI track record (86% success rate and 73% average return).

Overall, AERI boasts 100% Street support with 7 buy ratings in the last three months. These analysts believe (on average) that AERI can leap a further 32% in the coming months.

Stocks to Buy: Facebook (FB) Stocks to Buy: Facebook (FB)investorplace.com/wp-content/uploads/2017/11/fbmsn-300×150.jpg 300w, investorplace.com/wp-content/uploads/2017/11/fbmsn-768×384.jpg 768w, investorplace.com/wp-content/uploads/2017/11/fbmsn-60×30.jpg 60w, investorplace.com/wp-content/uploads/2017/11/fbmsn-200×100.jpg 200w, investorplace.com/wp-content/uploads/2017/11/fbmsn-400×200.jpg 400w, investorplace.com/wp-content/uploads/2017/11/fbmsn-116×58.jpg 116w, investorplace.com/wp-content/uploads/2017/11/fbmsn-100×50.jpg 100w, investorplace.com/wp-content/uploads/2017/11/fbmsn-78×39.jpg 78w, investorplace.com/wp-content/uploads/2017/11/fbmsn-800×400.jpg 800w,https://investorplace.com/wp-content/uploads/2017/11/fbmsn-170×85.jpg 170w” sizes=”(max-width: 950px) 100vw, 950px” />Source: Shutterstock

Social media giant Facebook Inc (NASDAQ:FB) has a big catalyst heading its way for 2018. The company has already premiered its ‘Watch’ tab, but 2018 could be the year where it really takes off. (Of course, this is on top of all the stock’s other catalysts like Instagram, WhatsApp and a new Direct messaging app.)

One of TipRanks’ top 100 analysts, Brent Thrill, believes the ‘Watch’ tab is about to make a sizeable impact on user video consumption. He says the tab will drive video engagement alongside improved network effects and sharing. Plus, Facebook’s data-driven approach to content and partner revenue share agreements is the smart way to go. He is now looking for revenue purely from the Watch tab to hit $12 billion in 2022. Thrill’s $225 price target suggests considerable upside of 27% from the current share price.

Strong Buy stock FB has scored 30 buy ratings and just 1 sell rating in the last three months. Meanwhile, the average analyst price target of $210 indicates 19% upside potential.

TipRanks offers investors the latest insight into eight different sectors by tracking the activity of 4,700 analysts, 5,000 financial bloggers and even 37,000 corporate insiders. As of this writing, Harriet Lefton did not hold a position in any of the aforementioned securities.

Compare Brokers

best stocks to own

Social Security retirement benefits are designed to replace about 40% of the average American worker’s earnings. However, the benefit formula is weighted in favor of lower-income workers and tends to replace less of higher earners’ pre-retirement income. With that in mind, let’s look at how much your Social Security benefit could be if you earn $100,000 per year throughout your career, which is on the higher end of the maximum earnings considered for Social Security benefits.

How the Social Security retirement benefit formula works

Your Social Security benefit is determined by your entire work record. Every year’s earnings of your entire career are indexed for inflation, and then the 35 highest are considered when calculating your benefit. If you don’t have 35 years of earnings, zeros will be used for the remaining years.

Image source: Getty Images.

best stocks to own: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

best stocks to own: CyberArk Software Ltd.(CYBR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Citigroup Inc (NYSE: C) to report quarterly earnings at $1.26 per share on revenue of $17.71 billion before the opening bell. Citigroup shares rose 0.30 percent to $67.22 in after-hours trading.
    Analysts are expecting JPMorgan Chase & Co. (NYSE: JPM) to have earned $1.65 per share on revenue of $25.61 billion in the latest quarter. JPMorgan will release earnings before the markets open. JPMorgan shares gained 0.48 percent to $93.55 in after-hours trading.
    Cyberark Software Ltd (NASDAQ: CYBR) lowered its guidance for the second quarter. The company now expects total revenue of $57.0 million to $57.5 million, versus earlier guidance of $61.0 million to $62.0 million. Cyberark shares dipped 17.65 percent to $42.00 in the after-hours trading session.
    Before the opening bell, First Republic Bank (NYSE: FRC) is projected to report quarterly earnings at $1.1 per share on revenue of $675.70 million. First Republic Bank shares dropped 0.80 percent to close at $101.35 on Thursday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By ]

    RB: I thought wed be up more than we are on cybersecurity plays. We have 25% gains on recommendations like Palo Alto Networks (NYSE: PANW). Were off a few percentage points on CyberArk Software (NASDAQ: CYBR).

  • [By Joe Tenebruso]

    CyberArk Software (NASDAQ:CYBR) reported fourth-quarter financial results on Feb. 9. The Israeli cybersecurity specialist continues to win new business for its “privileged account” security solutions, which help to protect against cyberattacks that use insider privileges to penetrate network perimeters and assault the most sensitive areas of an enterprise’s IT infrastructure.

best stocks to own: Pacira Pharmaceuticals, Inc.(PCRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Pacira Pharmaceuticals Inc (NASDAQ: PCRX) shares were also up, gaining 17 percent to $39.80. Pacira Pharmaceuticals reported preliminary 2016 revenue of $276.4 million.

  • [By Chris Lange]

    Pacira Pharmaceuticals Inc. (NASDAQ: PCRX) has announced preliminary unaudited total revenues and net product sales for Exparel for the fourth quarter and the full year. Total revenues were $72.9 million and $276.4 million for the fourth quarter and full year, respectively. Exparel net product sales were $71.4 million and $239.9 million for the same periods, respectively. The consensus estimates from Thomson Reuters were calling for revenues of $72.56 million in the fourth quarter and $276.09 million in the full year.

best stocks to own: Autobytel Inc.(ABTL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Autobytel Inc. (NASDAQ: ABTL) were down 26 percent to $8.05 as the company posted downbeat Q2 results and lowered its FY17 outlook. Barrington Research downgraded Autobytel from Outperform to Market Perform.

best stocks to own: Liberty Interactive Corporation(LVNTA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of General Communication, Inc. (NASDAQ: GNCMA) got a boost, shooting up 63 percent to $33.43 after Liberty Interactive Corporation (NASDAQ: LVNTA) announced plans to acquire General Communication for $1.12 billion.

best stocks to own: Western Union Company (The)(WU)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was The Western Union Co. (NYSE: WU) which jumped 3.6% to $20.28. The stocks 52-week range is $18.07 to $22.70. Volume was 11 million which is well above the daily average of around 5.8 million shares.

  • [By Brian Mathews]

    Western Union Co. (NYSE: WU) is the leading independent provider of consumer money transfer services. After a rough couple of years and dealing with compliance and regulatory issues, WU has finally weathered the storm. Market share has stabilized and revenues have been slowly growing. One of Western Union’s strengths is its size in the industry. The money-transfer business is highly scalable because the incremental costs of processing additional transactions are minimal. This allows WU to have operating margins that are twice as large as its closest competitor. Also, since WU is a highly recognizable brand, consumers flock to use its services in comparison to its peers. Western Union submitted a bid to buy the Australian company OzForex. If this deal goes through, it will provide additional scale to WU, especially to a market clientele that is more affluent. With the troubling times behind the company and expansion on the horizon, expect WU stock to appreciate to $24.

  • [By Ben Levisohn]

    Western Union (WU) soared to the top of the S&P 500 today after MoneyGram International (MGI) received a bid from Euronet Worldwide (EEFT).

    Agence France-Presse/Getty Images

    Shares of Western Union gained 3.5% to $20.27 today, while the S&P 500 fell 0.3% to 2,365.45.MoneyGram International surged 25% to $15.77, while Euronet Worldwide advanced 0.3% to $83.22.

    Normally, two competitors linking up to take on the dominant player in the industry might be considered bad news. BTIG’s Mark Palmer and Giuliano Bolognaexplain why the Western Union reaction”makes sense”:

    While the surge in shares of MoneyGram (MGI, Not Rated) in response to the announcement by Euronet Worldwides (EEFT, Not Rated) that it had offered to buy the company for $15.20 per share in cash was easy to understand the bid trumped the bid of $13.25 per share that MoneyGram received from Alibaba (BABA) affiliate Ant Financial in late January what may have been surprising to some was the positive reaction of shares of MGI remittance competitor Western Union (WU, Buy, $23 PT) to the news.

    With that said, we believe the uptick in WU shares makes some sense insofar as the competitive threat posed by EEFT may be perceived as less imposing than that represented by Ant, especially following reports in February that the latter was planning to raise as much as $3bn to fund global investments.

    We also believe the second bid for MGI serves to underline the attractiveness and potential of the global remittance space, an industry in which WU is the clear leader. Moreover, we think the bid may have given rise to the notion that WU could be an acquisition candidate for another deep-pocketed firm that could lever off its global footprint and the strength of its brand.

    Western Union’s market capitalization rose to $9.8 billion today, from $9.4 billion yesterday. It reported net income of $253 million on sales of $5.4 billion in

  • [By WWW.THESTREET.COM]

    You don’t need to be an expert technical trader to figure out the price action in shares of $10 billion payment services stock Western Union (WU) . Instead, the price action is more or less as simple as it gets. Since January, Western Union has been a “buy the dips stock”, bouncing its way higher in a well-defined uptrend. And shares are showing traders another buyable dip this week.

stock best

With evolving macro trends – an upswing in commodity prices, the recent OPEC agreement, and the President-Elect’s appointments of pro-oil cabinet members – giving favor to energy companies, I decided to look at the economics of various oil and gas producers. This analysis brought me to Carrizo Oil & Gas (NASDAQ: CRZO), a Houston-based Exploration and Production company with considerable acreage in the Eagle Ford and Niobrara shale formations.

Carrizo Oil & Gas’s recent presentation at the Goldman Sachs Global Energy Conference provided updates on the company’s acreage, well economics, and hedging. Analyzing the presentation, the company’s filings, and earnings calls reveals a company with well-positioned assets and sufficient liquidity.

Worth considering from the presentation is the ratio of the company’s acreage that performs well at both current oil prices and lower oil prices. Sure, some of the company’s holdings are excellent performers with oil prices back above $50/Bbl, but what about the company as a whole?

stock best: Pharmerica Corporation(PMC)

Advisors’ Opinion:

  • [By Monica Gerson]

    PharMerica Corporation (NYSE: PMC) is estimated to report its quarterly earnings at $0.43 per share on revenue of $509.45 million.

    United States Cellular Corp (NYSE: USM) is projected to report its quarterly earnings at $0.26 per share on revenue of $975.54 million.

stock best: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

stock best: China Automotive Systems, Inc.(CAAS)

Advisors’ Opinion:

  • [By Monica Gerson]

    China Automotive Systems, Inc. (NASDAQ: CAAS) is projected to post its quarterly earnings at $0.20 per share on revenue of $108.22 million.

    Affimed NV (NASDAQ: AFMD) is projected to post a quarterly loss at $0.18 per share on revenue of $1.71 million.

stock best: Bed Bath & Beyond Inc.(BBBY)

Advisors’ Opinion:

  • [By Trey Thoelcke]

    Bed Bath & Beyond Inc. (NASDAQ: BBBY) is scheduled to report its fiscal third-quarter results after trading ends on Wednesday. The consensus analyst estimates are $0.99 in EPS and revenue of $3.01 billion. Shares ended trading on Friday at $47.27. The consensus price target is $42.76. The 52-week range is $38.60 to $52.71.

  • [By Peter Graham]

    Mid caphomed茅cor retailer Bed Bath & Beyond Inc (NASDAQ: BBBY) reportedfiscal Q2 2017 earnings after the market closed on Tuesday with shares falling in the low double digits as results were far below expectations on restructuring and hurricane-related issues. Net sales decreased approximately 1.7% to $2.9 billion as comparable sales decreased by approximately 2.6% (primarily due to a 2.6% decrease in comp sales, partially offset by an increase of 0.9% in non-comp sales).Comparable sales from customer-facing digital channels continued to have strong growth in excess of 20% for the 13th consecutive quarter, while comparable sales from stores declined in the mid-single-digit percentage range during the fiscal 2017 second quarter. Net earningswere $.67 per diluted share ($94.2 million), including the unfavorable impacts of approximately $.08 per diluted share of cash restructuring charges associated with the acceleration of the realignment of store management structure announced on August 3, 2017; the estimated costs associated with the impact of Hurricane Harvey of approximately $.02 per diluted share; and the impact of the new share-based payment accounting standard of approximately $.01 per diluted share, versus $1.11 per diluted share ($167.3 million) for the fiscal 2016 second quarter.

  • [By WWW.THESTREET.COM]

    Shares of Bed Bath & Beyond (BBBY) took a bath today, Cramer told viewers, and is likely beyond hope.

    The home-goods retailer posted a huge earnings miss, delivering just 53 cents a share when the analysts were expecting 66 cents a share. Making matters worse, the company also saw a 2% decline in same-store sales.

  • [By Trey Thoelcke]

    Bed Bath & Beyond Inc. (NASDAQ: BBBY) is expected to release its fiscal third-quarter quarterly results later on Wednesday. The consensus forecast calls for $0.37 in EPS and $2.90 billion in revenue. Shares ended the week at $22.62. The consensus price target is $23.88, and the 52-week range is $19.07 to $47.57.

playing the stock market

The stock market lost ground on Thursday, but declines in the major benchmarks were relatively modest as low levels of volatility continued to prevail. The Dow had been down as much as 145 points earlier in the day as investors weighed the possibility that the controversial firing of FBI Director James Comey could set back the Trump administration’s domestic agenda for tax cuts, health reform, and immigration. In addition, bad news among several major retailers weighed on market sentiment.

But some stocks managed to buck the trend and give investors more upbeat outlooks for their prospects. SandRidge Energy (NYSE: SD), MBIA (NYSE:MBI), and LivePerson (NASDAQ:LPSN) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

SandRidge gives investors a good report

Shares of SandRidge climbed 10% after the company reported its first-quarter financial results. The energy company said that it earned a profit of $50.8 million, which worked out to $1.90 per share, reversing a loss in the year-ago period prior to SandRidge’s emergence from bankruptcy in late 2016. SandRidge produced 4 million barrels of oil equivalent during the quarter, half of which was dry natural gas and the remainder split between crude oil and natural gas liquids. Lifting costs rose slightly during the quarter, but SandRidge continued to benefit from efforts to improve operating efficiency. In total, the energy company expects to produce between 14 million and 14.7 million barrels of oil equivalent during 2017, and it’s working hard to minimize discounts compared to West Texas Intermediate crude and Henry Hub spot natural gas prices and reap the most in profit that it can.

playing the stock market: ANSYS, Inc.(ANSS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.

playing the stock market: Clarke(t)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    With a dividend yield of 4.8%, AT&T (T) will continue to be an attractive income investment whether or not the merger with Time Warner (TWX) happens. AT&T recently completed other deals that have increased earnings and strengthened dividend safety.

  • [By Adam Levy]

    As more consumers cut the cord, competition in the pay-TV industry is growing increasingly fierce. That’s led some companies to seek consolidating acquisitions like AT&T (NYSE:T) did last year by buying DIRECTV. Others, meanwhile, have sought to attract subscribers with low-priced bundles and over-the-top packages like DISH Network’s (NASDAQ:DISH) Sling TV.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Thursday was AT&T Inc. (NYSE: T) which traded down 2.2% at $40.61. The stocks 52-week range is $36.10 to $43.89. Volume was roughly 16.8 million versus the daily average of 19.2 million shares.

playing the stock market: B Communications Ltd.(BCOM)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, telecommunications services shares fell by 0.77 percent. Meanwhile, top losers in the sector included United States Cellular Corp (NYSE: USM), down 5 percent, and B Communications Ltd (NASDAQ: BCOM), down 5 percent.

  • [By Lisa Levin]

    In trading on Monday, telecommunications services shares rose by just 0.2 percent. Meanwhile, top losers in the sector included B Communications Ltd (NASDAQ: BCOM), down 4 percent, and Partner Communications Company Ltd (ADR) (NASDAQ: PTNR), down 2 percent.

playing the stock market: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

Top 10 Blue Chip Stocks To Invest In 2018

The stock market gave up ground on Tuesday, but investors saw major benchmarks recover from their worst levels of the day to finish down less than half a percent. Early in the day, poor earnings results from blue chip components of the Dow Jones Industrials weighed on market sentiment, and ongoing uncertainty about whether the Trump administration will be able to deliver on promised government reforms made some investors feel less confident about the future. However, several companies reported good news despite the dour mood on Wall Street, and GNC Holdings (NYSE:GNC), Stratasys (NASDAQ:SSYS), and Cabela’s (NYSE:CAB) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

GNC eases shareholders’ concerns

Shares of GNC Holdings jumped 24% after the company posted first-quarter results that, while not perfect, were still not as bad as some investors had feared. Revenue fell 4% from year-ago levels, and same-store sales dropped 3.9% in company-owned locations and 4.6% in domestic franchise stores. Moreover, net income dropped by more than half, leaving the company with just $0.37 per share in adjusted earnings. Yet those numbers encouraged those who are patient enough to give GNC time to remake itself, and CEO Bob Moran pointed to the company’s One New GNC transformation strategy as having shown signs of early success. With new loyalty programs producing some positive effects on transaction counts and volume, GNC hopes that business metrics will hit bottom and start to grow again in the near future.

Top 10 Blue Chip Stocks To Invest In 2018: CGG(CGG)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday afternoon, the energy sector proved to be a source of strength for the market. Leading the sector was strength from CGG SA (ADR) (NYSE: CGG) and Geospace Technologies Corporation (NASDAQ: GEOS).

  • [By Jonas Elmerraji]

    First up is French oil service firm CGG Veritas (CGG)
    . The Eurozone-based energy stock hasn’t exactly posted blockbuster performance in 2013, but investors who ignore CGG for the final stretch of the year could be making a big mistake. That’s because of a bullish technical pattern that’s emerging in shares right now.

    CGG spent most of the last eight months looking anything but bullish. But an ascending triangle pattern is changing that. The pattern is formed by horizontal resistance to the upside at $26, and uptrending support to the below shares. Basically, as CGG bounces in between those two technical levels, it’s getting squeezed closer and closer to a breakout above $26. When that happens, traders have a buy signal.

    The ascending triangle pattern in CGG Veritas isn’t exactly textbook. That’s because the setup is forming at the bottom of a downtrend, rather than in the middle of an uptrend – but it’s a mistake to get caught up on the textbook pictures of what trading patterns are supposed to look like. On a move through $26, the trading implications are just as actionable.

  • [By Lisa Levin]

    CGG SA (ADR) (NYSE: CGG) shares shot up 32 percent to $7.15 after the company reported an agreement in principle on financial restructuring plan with main creditors and DNCA.

Top 10 Blue Chip Stocks To Invest In 2018: Nuveen Municipal Value Fund Inc.(NUV)

Advisors’ Opinion:

  • [By Donald van Deventer]

    The latest implied forward rate forecast from Kamakura Corporation shows projected 10-year U.S. Treasury yields differing -0.07% to 0.03% from last week while fixed rate mortgage yields varied by -0.01% to 0.08%. Mortgage yields, determined by the Monday through Wednesday weekly survey of the Federal Home Loan Mortgage Corporation, lag Treasury movements simply because of the 3-day yield calculation used in the Primary Mortgage Market Survey. The 10-year U.S. Treasury yield is projected to rise from 2.92% at Thursday’s close (down 0.06% from last week) to 3.374% (down 0.06% from last week) in one year. The 10-year U.S. Treasury yield in ten years is forecast to reach 4.639%, 1 basis point lower than last week. The 15-year fixed rate mortgage rate is forecast to rise from the effective yield of 3.69% on Thursday (down 0.001% from last week) to 4.222% (down 0.006% from last week) in one year and 6.29% in 10 years, up 0.038% from last week. We explain the background for these calculations in the rest of this note, along with some mortgage servicing rights metrics. The forecast allows investors in exchange traded U.S. Treasury funds (TLT) (TBT), total return bond funds (BOND), municipal bonds (NUV) and exchange traded mortgage funds (REM) to assess likely total returns over the next 120 months. Treasury-related exchange traded funds affected by the forward rates include:

Top 10 Blue Chip Stocks To Invest In 2018: Luxoft Holding, Inc.(LXFT)

Advisors’ Opinion:

  • [By Steve Symington]

    Luxoft Holding(NYSE:LXFT)announced strong fiscal fourth-quarter results on Monday, after the market closed. Similar to its modest post-earnings drop in February, shares of the software development specialist fell 3.6% on Tuesday as investors absorbed the news.

Top 10 Blue Chip Stocks To Invest In 2018: Madison Square Garden Inc.(MSG)

Advisors’ Opinion:

  • [By Monica Gerson]

    Madison Square Garden Co (NYSE: MSG) is estimated to report a quarterly loss at $0.34 per share on revenue of $325.53 million.

    Gogo Inc (NASDAQ: GOGO) is projected to report a quarterly loss at $0.42 per share on revenue of $137.58 million.

  • [By Ian Wyatt, Publisher & Chief Investment Strategist, Wyatt Investment Research]

    Meanwhile, Mark Boyar, of The Boyar Value Fund, recommends another household name: Madison Square Garden (MSG). He thinks the Dolan family could take the company private.

Top 10 Blue Chip Stocks To Invest In 2018: Salesforce.com Inc(CRM)

Advisors’ Opinion:

  • [By Chris Lange]

    Salesforce.com Inc. (NYSE: CRM) is expected to release its fiscal second-quarter financial earnings report after the markets close on Tuesday. The consensus estimates from Thomson Reuters call for $0.32 in earnings per share (EPS) and $2.51 billion in revenue. The same period of last year reportedly had EPS of $0.24 and $2.04 billion in revenue.

  • [By WWW.THESTREET.COM]

    “There are two things that mess up your relationships, it’s anger and fear,” explains Robbins. Robbins points to Salesforce (CRM) CEO Marc Benioff as being a total giver, which has set him up for success in business.

  • [By Craig Jones]

    Jon Najarian spoke on CNBC's Fast Money Halftime Report about bullish options activity in Salesforce.com, inc. (NYSE: CRM) and Apple Inc. (NASDAQ: AAPL).

  • [By Douglas A. McIntyre]

    By Douglas A. McIntyre

    « Intel’s Place in a Changing AMD and NVIDIA World 13 Cars That Compete with the Tesla Model 3 »
    Read more: Investing, Salesforce.com (NYSE:CRM), Walt Disney (NYSE:DIS), GOOGL, Microsoft (NASDAQ:MSFT), Twitter, Inc. (NYSE:TWTR)

    Free Daily Newsletter
    Subscribe

    Terms & Conditions

    Popular 10 Disappearing Car BrandsCustomer Service Hall of ShameThe Best and Worst Run States in America: A Survey of All 5026 National Monuments President Trump Wants to Shut DownCompanies Stashing the Most Money Overseas Recent A

  • [By Craig Jones]

    On CNBC’s “Fast Money Halftime Report,” Jon Najarian said he noticed unusually high bullish options activity in Salesforce.com, inc. (NYSE: CRM) and SPDR S&P Retail (ETF) (NYSE: XRT).

  • [By WWW.THESTREET.COM]

    “There are two things that mess up your relationships, it’s anger and fear,” explains Robbins. Robbins points to Salesforce (CRM) CEO Marc Benioff as being a total giver, which has set him up for success in business.

Top 10 Blue Chip Stocks To Invest In 2018: Towerstream Corporation(TWER)

Advisors’ Opinion:

  • [By Lisa Levin]

    Towerstream Corporation (NASDAQ: TWER) shares were also up, gaining 9 percent to $3.49. Towerstream is scheduled to report Q2 financial results on August 9, 2016.

Top 10 Blue Chip Stocks To Invest In 2018: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

Top 10 Blue Chip Stocks To Invest In 2018: MGM Resorts International(MGM)

Advisors’ Opinion:

  • [By Craig Jones]

    Jon Najarian noticed some call options activity in MGM Resorts International (NYSE: MGM). Traders were buying the September 32/37 call spread in the first half of the session on Thursday. Najarian likes the trade and he decided to initiate a long position in MGM Resorts.

  • [By Rich Duprey]

    The big casinos certainly want to spend big. Las Vegas Sands (NYSE:LVS) says a new integrated resort in Japan will cost anywhere from $6 billion to $10 billion, two to three times more than it spent on building its brand new French-themed Parisian resort in Macau. MGM Resorts (NYSE:MGM) says it, too, could spend $10 billion for a new casino in Japan, quadruple the cost of its MGM Cotai that’s scheduled to open later this year. Wynn Resorts (NASDAQ:WYNN) hasn’t put a price tag on it yet, though it spent over $4 billion to open the Palace in Macau last August, but CEO Steve Wynn says the opportunity is “thoroughly delicious.”

  • [By Ben Levisohn]

    With companies like Under Armour (UAA), MGM Resorts International (MGM), andUnited Parcel Service (UPS) reporting tomorrow, we thought we’d get a jump start on the stocks moving after today’s close:

Top 10 Blue Chip Stocks To Invest In 2018: Xerox Corporation(XRX)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Xerox Corp. (NYSE: XRX) which rose 3.8% to $30.56. The stocks 52-week range is $22.90 to $30.76. Volume was 3.8 million compared to its average volume of 2.3 million.

  • [By Paul Ausick]

    Xerox Corp. (NYSE: XRX) dropped about 23% on Tuesday to post a new 52-week low of $6.46 after closing at $8.73 on Friday. The dip was the result of the company’s completed separation into two firms this morning. After the early drop shares had gained around 17% by late afternoon, probably on the strength of a cash payment of $1.8 billion.

Top 10 Blue Chip Stocks To Invest In 2018: Nordic American Tankers Limited(NAT)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nordic American Tankers Ltd. (NYSE: NAT) dropped about 2.4% Wednesday to post a new 52-week low of $2.49 after closing at $2.55 on Tuesday. Volume was around 2.8 million, about double the daily average of around 1.4 million. The firm sent shareholders a letter Tuesday morning explaining the shipper’s recapitalization program. The explanation did not sell any better today.

  • [By Paul Ausick]

    Nordic American Tankers Ltd. (NYSE: NAT) dropped about 3% Tuesday to post a new 52-week low of $2.51 after closing at $2.59 on Monday. Volume was around 2.8 million, about double the daily average of around 1.4 million. The firm sent shareholders a letter Monday morning explaining the shipper’s recapitalization program. Apparently the explanation did not sit well.

  • [By Paul Ausick]

    Nordic American Tankers Ltd. (NYSE: NAT) dropped about 4.8% Monday to post a new 52-week low of $2.58 after closing at $2.71 on Friday. Volume was around 2.8 million, more than double the daily average of around 2.3 million. The firm sent shareholders a letter this morning explaining the shipper’s recapitalization program.

  • [By Paul Ausick]

    Nordic American Tankers Ltd. (NYSE: NAT) posted a new 52-week low of $2.68 Wednesday, down about 27% after closing at $3.67 on Tuesday. The 52-week high is $9.32. Volume was about 20.3 million, more than 20 times the daily average of around 940,000 shares. The company announced priced a sale of $110 million in new shares at $2.75 per share.

  • [By Paul Ausick]

    Nordic American Tankers Ltd. (NYSE: NAT) posted a new 52-week low of $2.64 Thursday, down a penny after closing at $2.65 on Wednesday. The 52-week high is $9.32. Volume was about 4.5 million, more than 3 times the daily average of around 1.3 million shares. The company announced Wednesday morning that it had priced a sale of $110 million in new shares at $2.75 per share.

  • [By Lisa Levin]

    Shares of Nordic American Tanker Ltd (NYSE: NAT) were down 25 percent to $2.74 after announcing a $100 million common stock offering.

    ArcBest Corp (NASDAQ: ARCB) was down, falling around 10 percent to $34.85. Stifel Nicolaus downgraded ArcBest from Hold to Sell.

usa stock exchange

What happened

Shares ofLumber Liquidators Holdings, Inc.(NYSE:LL) were moving higher last month, though there was little company-specific news out on the stock. The retailer of wood flooring and other related products had been battered in recent years after a scandal involving illegally treated flooring, but investor confidence seemed to be returning along with a general uptick in home-improvement stocks. According to data from S&P Global Market Intelligence, the stock rose 18.4% in March.

Image source: Lumber Liquidators.

As the chart below shows, the gains mostly came during the last few days of the month.

LL data by YCharts.

So what

Lumber Liquidators stock reached its highest point in nearly two years on the rally, a sign that investor confidence is returning. As a cyclical, home-improvement retailer, Lumber Liquidators is the type of stock that should have benefited from the post-election rally, but shares continued to trade flat in the intervening months.

usa stock exchange: Boeing Company (The)(BA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    When you look at the stocks that have led us higher–Goldman Sachs (GS) , JPMorgan (JPM) , Travelers (TRV) , United Health (UNH) , Walt Disney (DIS) , American Express  (AXP) , Verizon (VZ) , Boeing (BA) , Caterpillar (CAT) and Chevron (CVX) , all up more than 10%–you come up with stocks where there just aren’t a lot of profit-takers.

  • [By Paul Ausick]

    The Boeing Co. (NYSE: BA) traded up 1.23% at $151.61. The stock’s 52-week range is $102.10 to $152.11, and a new 52-week high was posted this afternoon. Volume was about 15% lower than the daily average of around 3.6 million shares. The aircraft maker had no specific news, but arch-rival Airbus announced that it is laying off 1,100 workers.

  • [By Paul Ausick]

    Boeing Co. (NYSE: BA) reported Thursday morning that it delivered a total of 748 commercial jets in 2016, slightly above its delivery target of 740 to 745 commercial planes. Boeing delivered 185 commercial planes in the fourth quarter.

  • [By WWW.THESTREET.COM]

    Unlike Boeing (BA) , which could take years to benefit from a stronger economy, Cintas is what’s known as a short-cycle company, one that will see the benefits almost immediately.

  • [By William Patalon III]

    Two of our favorite U.S. heavyweights – The Boeing Co. (NYSE: BA) and Ford Motor Co. (NYSE: F) – are pushing forward with plans to put factories in China, positioning themselves to be winners in the part of the world where we’ll see the most growth in the decade to come.

  • [By WWW.THESTREET.COM]

    Private equity giant Blackstone (BX) on Saturday announced that Saudi Arabia would invest $20 billion in a new $40 billion infrastructure fund for projects mainly in the United States. On Sunday, Boeing (BA) said it had signed several defense and commercial deals with Saudi Arabia. Trump was referenced in both deal announcements.

usa stock exchange: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

usa stock exchange: ConAgra Foods, Inc.(CAG)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    Despite its growing revenue, the company underperformed as compared with the industry average of 2.3%. Since the same quarter one year prior, revenues slightly increased by 1.1%. Growth in the company’s revenue appears to have helped boost the earnings per share.

     

  • [By Lisa Levin]

    Conagra Brands Inc (NYSE: CAG) reported stronger-than-expected earnings for its third quarter.

    Conagra reported Q3 earnings of $0.48 per share on revenue of $1.98 billion. Analysts were expecting earnings of $0.44 per share on revenue of $1.98 billion.

  • [By Laurie Kulikowski]

    Following 1) the recent sale of its Private Brands segment, 2) the announcement of the spin-off of Lamb Weston, 3) commentary around improving its margin structure in the Consumer segment, and 4) management’s recognition that the company has not raised its dividend in years, we think CAG is heading in the right direction. For income-oriented investors, note that CAG has a great deal of cash coming in from the Private Brands sale, and that management has stated its commitment to a strong dividend. As noted above, CAG is our best idea heading into new year. 

  • [By Laurie Kulikowski]

    CONAGRA FOODS INC reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, CONAGRA FOODS INC swung to a loss, reporting -$1.49 versus $0.35 in the prior year. This year, the market expects an improvement in earnings ($2.26 versus -$1.49).

     

  • [By Laurie Kulikowski]

    Looking at where the stock is today compared to one year ago, we find that it is not only higher, but it has also clearly outperformed the rise in the S&P 500 over the same period. Although other factors naturally played a role, the company’s strong earnings growth was key. Looking ahead, our view is that this company’s fundamentals will not have much impact in either direction, allowing the stock to generally move up or down based on the push and pull of the broad market.

     

usa stock exchange: Abeona Therapeutics Inc.(ABEO)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested shorting small cap rare disease stock Abeona Therapeutics Inc (NASDAQ: ABEO):

    Abeona Therapeutics is clearly a timing trade – we think today’s something of a blowoff top, marked by a volume surge and the fact that the stock’s already peeling back from its peak; the profit-takers are already going to work. We saw a similar surge on Tuesday, and though that one didn’t end up kick-starting a pullback, it helped set up today’s reversal bar (by virtue of luring in the last of the would-be buyers). There’s just not a lot of room left for more upside.

  • [By Jim Robertson]

    Small and micro cap stocks can obviously be a fickle bunch, but I sure hope all of you participated in Abeona Therapeutics Inc. (ABEO) back when we first put the idea out there in early June. What a tremendous stock this has been for all of us, and it’s not like this happens all of the time.

usa stock exchange: Roadrunner Transportation Systems, Inc(RRTS)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Tuesday was another down day for the Dow Jones Industrials, which fell more than 100 points to drop further below the 20,000 level. But broader market measures were mixed, and the Nasdaq Composite even managed to gain ground. Continued uncertainty about the impact of new policies from the U.S. federal government have kept markets a bit turbulent, and the beginning of a two-day meeting of the Federal Reserve’s Open Market Committee could set the tone for monetary policy in 2017. Some stocks had bad news that sent them lower today, and among the worst performers were Seadrill (NYSE:SDRL), Roadrunner Transportation Systems (NYSE:RRTS), and Tempur Sealy International (NYSE:TPX). Below, we’ll look more closely at these stocks to tell you why they did so poorly.

usa stock exchange: HubSpot, Inc.(HUBS)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Cramer was bearish on Ferrellgas Partners (FGP) , Realty Income (O) , Synergy Pharmaceuticals (SGYP) , Avis Budget Group (CAR) and HubSpot (HUBS) .

  • [By Danny Vena]

    There’s another area being driven by AI that may surprise you. The next time you text your bank, cellphone service provider, or retailer, the agent you’re dealing with might be a chatbot. This form of conversational AI is being more widely adopted to perform simple customer service tasks. According to research conducted by marketing technology vendor HubSpot, Inc. (NYSE:HUBS), of 1,426 respondents worldwide, 74% had used voice search in the prior month, and 63% of people using services based on AI technology didn’t even know it.

top ten stocks to buy

Will Q3 earnings propel Wal-Mart Stores Inc (NYSE:WMT) stock to $100 mark?
Flickr [Update:Walmart delivered a beat on both the top and bottom line numbers in its third-quarter earnings release. The brick and mortar retail store chain reported non-GAAP EPS of $1.0 per share surpassing the high end of its own guidance, beating analysts estimates by 3 cents. On the top line front, the retailer reported revenues of$123.2 billion, up 4.2% YoY, and $2.2 billion more than what analysts were expecting. The company’seCommerce growth in the US remained strong, as Net sales and GMV increased 50% and 54%, respectively. The retail giant also increased its full yearEPS guidance to $4.38-$4.46 from $4.30-$4.40.]

Shares of Bentonville, Arkansas-based offline retail giant Wal-Mart Stores Inc (NYSE:WMT) have come to life in 2017 and are having their best run in recent years, up nearly 30% in the year-to-date. Walmart stock’s recent bull run has increased the expectations from its fiscal third-quarter earnings, which is scheduledfor today before the opening bell. WMT stock has been on a steady uptrend going into earnings since the beginning of October but closed in the red during yesterday’s trade. Wall Street is also turning more bullish about the prospects of thebrick-and-mortar retail behemoth ahead of earnings as Rupesh Parikh ofOppenheimer raised his price target on the Walmart stock to $100 and reiterated his Outperform rating. Now, the question is, can Q3 earnings set WMT stock on a post-earnings rally?

top ten stocks to buy: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

top ten stocks to buy: Gibraltar Industries, Inc.(ROCK)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, basic materials shares fell by 0.82 percent. Meanwhile, top losers in the sector included Gibraltar Industries Inc (NASDAQ: ROCK), down 9 percent, and Yamana Gold Inc. (USA) (NYSE: AUY), down 9 percent.

  • [By Lisa Levin]

    In trading on Tuesday, basic materials shares fell 0.44 percent. Meanwhile, top losers in the sector included Haynes International, Inc. (NASDAQ: HAYN), down 5 percent, and Gibraltar Industries Inc (NASDAQ: ROCK), down 4 percent.

top ten stocks to buy: USG Corporation(USG)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    USG Corp. (NYSE: USG) was reiterated as Hold but the price target was raised to $35 from $29 (versus a $34.23 close) at Jefferies.

    Thursday’s top analyst upgrades and downgradesincluded Biogen, Goldcorp, GoPro, Oracle, Sirius XM, Tyson Foods, Ciena and many more.

  • [By The Ticker Tape]

    Homebuilders like Lennar, PulteGroup, Inc. (NYSE: PHM), and D.R. Horton, Inc. (NYSE: DHI) could benefit from a strengthening housing recovery. If you’re bullish on housing, you might want to take a step back and think about other companies in that space. Home improvement stores like Home Depot Inc (NYSE: HD) and Lowe's Companies, Inc. (NYSE: LOW) could get a boost as well as companies that supply products for new homes like Whirlpool Corporation (NYSE: WHR) and USG Corporation(NYSE: USG).

top ten stocks to buy: Renewable Energy Group, Inc.(REGI)

Advisors’ Opinion:

  • [By Manikandan Raman]

    There also some lesser known clean energy stocks that may witness downward movement on potential Trump win on negative sentiment. They include Pattern Energy Group Inc (NASDAQ: PEGI), Enviva Partners LP (NYSE: EVA), TerraForm Global Inc (NASDAQ: GLBL), Renewable Energy Group Inc (NASDAQ: REGI) and Ameresco Inc (NYSE: AMRC).

top ten stocks to buy: Berjaya Sports Toto Berhad (BJSAF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Listed on the Malaysian Bursa and also traded over the US OTC markets (OTCPK:BJSAF), Berjaya Sports Toto (BToto) is a Malaysian company primarily engaged in toto betting, leasing of online lottery equipment, and the manufacture and distribution of computerized lottery and voting systems. As part of its diversification plans, BToto also operates a hotel in the Philippines and retails luxury motor brands in the UK.